<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: DNA-damaging drugs constitute standard chemotherapy regimen for advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, the interactions between <z:chebi fb="0" ids="16243">quercetin</z:chebi> and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU), <z:chebi fb="0" ids="4911">etoposide</z:chebi>, and <z:chebi fb="0" ids="27656">camptothecin</z:chebi> were examined in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: HCT116 colorectal or PPC1 <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> cells were treated with <z:chebi fb="0" ids="16243">quercetin</z:chebi> and the drugs </plain></SENT>
<SENT sid="3" pm="."><plain>Clonogenicity assays, cell cycle profiles, and expressions of p53, p21, BAX, survivin and cyclin B1 proteins were used to examine the effects of the treatments </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:chebi fb="0" ids="16243">Quercetin</z:chebi> synergistically inhibited the clonogenicity of the <z:mp ids='MP_0002169'>wild-type</z:mp> cells, but inhibited the cell cycle effects of <z:hpo ids='HP_0000001'>all</z:hpo> the drugs tested </plain></SENT>
<SENT sid="5" pm="."><plain>In p53-null cells, the combination of low dose 5-FU with up to 6 μM <z:chebi fb="0" ids="16243">quercetin</z:chebi> promoted clonogenic survival </plain></SENT>
<SENT sid="6" pm="."><plain>Treatment of p53-<z:mp ids='MP_0002169'>wild-type</z:mp> cells with 50 μM <z:chebi fb="0" ids="16243">quercetin</z:chebi> reduced drug-induced up-regulation of p53, p21 and BAX </plain></SENT>
<SENT sid="7" pm="."><plain>The combination of <z:chebi fb="0" ids="16243">quercetin</z:chebi> and the drugs also reduced the levels of cyclin B1 and survivin proteins </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: While high doses of <z:chebi fb="0" ids="16243">quercetin</z:chebi> synergize with DNA-damaging agents, the effect of drug combination with <z:chebi fb="0" ids="16243">quercetin</z:chebi> is influenced by the effective doses and the p53 status of the cells </plain></SENT>
</text></document>